Latest stories on BNTC
Benitec Biopharma (BNTC) Reports Promising Interim Results for BB-301 in OPMD Trial
GuruFocus64 · neutralproduct/pr
Benitec Biopharma announces interim results from BB-301 trial
The Fly56 · neutralproduct/pr
Benitec Biopharma Inc. (BNTC) files 8-K
SEC 8-K50 · neutralgeneral
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
GlobeNewswire74 · bullishproduct/pr
Raymond James initiates Benitec BioPharma stock with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
Benitec Biopharma initiated with an Outperform at Raymond James
The Fly63 · neutralanalyst
Citizens reiterates Benitec Biopharma stock rating on FDA feedback
Investing.com Analyst Ratings55 · neutralanalyst
Benitec Biopharma says BB-301 pivotal still on track for mid-2027
The Fly63 · neutralproduct/pr
Benitec advances BB-301 gene therapy after FDA feedback
TipRanks63 · neutralproduct/pr
Benitec Biopharma Inc. (BNTC) files 8-K
SEC 8-K50 · neutralgeneral
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
StockTitan63 · neutralproduct/pr
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
GlobeNewswire63 · neutralproduct/pr
Benitec Biopharma Inc. (BNTC) files 8-K
SEC 8-K50 · neutralgeneral
H.C. Wainwright reiterates Benitec Biopharma stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Benitec Biopharma Inc. (BNTC) files 8-K
SEC 8-K50 · neutralgeneral
Benitec Biopharma price target raised to $17 from $16 at Wedbush
The Fly61 · neutralanalyst
Citizens reiterates Benitec Biopharma stock rating ahead of FDA talks
Investing.com Analyst Ratings56 · neutralanalyst
Benitec Biopharma files $200M mixed securities shelf
The Fly24 · bearishgeneral
Benitec Biopharma Inc. (BNTC) files 8-K
SEC 8-K50 · neutralgeneral
Benitec GAAP EPS of -$0.98 in-line
Seeking Alpha50 · neutralearnings
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
GlobeNewswire56 · neutralearnings
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Business Insider55 · neutralearnings
Benitec Biopharma Announces Board Changes and New Director
TipRanks50 · neutralgeneral
Benitec GAAP EPS of -$0.24 beats by $0.04
Seeking Alpha56 · neutralearnings